Scleroderma Approved For DOD Funding for FY17
Thanks to your advocacy efforts, scleroderma remains on the "approved" list for funding as part of the FY2017 Peer-Reviewed Medical Research Program (PRMRP) by the U.S. Department of Defense (DOD).
The funding opportunity announcements for FY2017 have been released by the DOD:
Dept. of the Army -- USAMRAA
- Patients & Newly Diagnosed
- Healthcare Professionals